Literature DB >> 4353012

A clinicopathologic analysis of adriamycin cardiotoxicity.

E A Lefrak, J Pitha, S Rosenheim, J A Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4353012     DOI： 10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  323 in total

Review 1.  Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors:  D Jain
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

3.  Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes.

Authors:  Ana Ludke; Anita K Sharma; Ashim K Bagchi; Pawan K Singal
Journal:  Mol Cell Biochem       Date:  2011-09-22       Impact factor: 3.396

4.  The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.

Authors:  Lynda M Vrooman; Donna S Neuberg; Kristen E Stevenson; Barbara L Asselin; Uma H Athale; Luis Clavell; Peter D Cole; Kara M Kelly; Eric C Larsen; Caroline Laverdière; Bruno Michon; Marshall Schorin; Cindy L Schwartz; Harvey J Cohen; Steven E Lipshultz; Lewis B Silverman; Stephen E Sallan
Journal:  Eur J Cancer       Date:  2011-04-20       Impact factor: 9.162

Review 5.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

6.  Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.

Authors:  Venkat Subramaniam; Gin Chuang; Huijing Xia; Brendan Burn; Jessica Bradley; Jerome L Maderdrut; David H Coy; Kurt J Varner
Journal:  Peptides       Date:  2017-07-15       Impact factor: 3.750

Review 7.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 8.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.

Authors:  Brian C Jensen; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533

9.  Early detection of doxorubicin cardiotoxicity by M-mode echocardiography.

Authors:  W Markiewicz; E Robinson; B Peled; S Kaufman; A Carter
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 10.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.